Makeda K Stephenson1,2, Ashley L Farris1,2, Warren L Grayson3,4,5,6. 1. Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, 400 N. Broadway, Smith Building 5023, Baltimore, MD, 21231, USA. 2. Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 3. Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, 400 N. Broadway, Smith Building 5023, Baltimore, MD, 21231, USA. wgrayson@jhmi.edu. 4. Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA. wgrayson@jhmi.edu. 5. Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, USA. wgrayson@jhmi.edu. 6. Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, USA. wgrayson@jhmi.edu.
Abstract
PURPOSE OF REVIEW: While the clinical potential of tissue engineering for treating joint damage has yet to be realized, research and commercialization efforts in the field are geared towards overcoming major obstacles to clinical translation, as well as towards achieving engineered grafts that recapitulate the unique structures, function, and physiology of the joint. In this review, we describe recent advances in technologies aimed at obtaining biomaterials, stem cells, and bioreactors that will enable the development of effective tissue-engineered treatments for repairing joint damage. RECENT FINDINGS: 3D printing of scaffolds is aimed at improving the mechanical structure and microenvironment necessary for bone regeneration within a damaged joint. Advances in our understanding of stem cell biology and cell manufacturing processes are informing translational strategies for the therapeutic use of allogeneic and autologous cells. Finally, bioreactors used in combination with cells and biomaterials are promising strategies for generating large tissue grafts for repairing damaged tissues in pre-clinical models. Together, these advances along with ongoing research directions are making tissue engineering increasingly viable for the treatment of joint damage.
PURPOSE OF REVIEW: While the clinical potential of tissue engineering for treating joint damage has yet to be realized, research and commercialization efforts in the field are geared towards overcoming major obstacles to clinical translation, as well as towards achieving engineered grafts that recapitulate the unique structures, function, and physiology of the joint. In this review, we describe recent advances in technologies aimed at obtaining biomaterials, stem cells, and bioreactors that will enable the development of effective tissue-engineered treatments for repairing joint damage. RECENT FINDINGS: 3D printing of scaffolds is aimed at improving the mechanical structure and microenvironment necessary for bone regeneration within a damaged joint. Advances in our understanding of stem cell biology and cell manufacturing processes are informing translational strategies for the therapeutic use of allogeneic and autologous cells. Finally, bioreactors used in combination with cells and biomaterials are promising strategies for generating large tissue grafts for repairing damaged tissues in pre-clinical models. Together, these advances along with ongoing research directions are making tissue engineering increasingly viable for the treatment of joint damage.
Authors: Ana Revilla; Clara González; Amaia Iriondo; Bárbara Fernández; Cristina Prieto; Carlos Marín; Isabel Liste Journal: J Tissue Eng Regen Med Date: 2015-03-11 Impact factor: 3.963
Authors: Franziska Saxer; Arnaud Scherberich; Atanas Todorov; Patrick Studer; Sylvie Miot; Simone Schreiner; Sinan Güven; Laurent A H Tchang; Martin Haug; Michael Heberer; Dirk J Schaefer; Daniel Rikli; Ivan Martin; Marcel Jakob Journal: Stem Cells Date: 2016-09-16 Impact factor: 6.277
Authors: Joseph L Dieleman; Ranju Baral; Maxwell Birger; Anthony L Bui; Anne Bulchis; Abigail Chapin; Hannah Hamavid; Cody Horst; Elizabeth K Johnson; Jonathan Joseph; Rouselle Lavado; Liya Lomsadze; Alex Reynolds; Ellen Squires; Madeline Campbell; Brendan DeCenso; Daniel Dicker; Abraham D Flaxman; Rose Gabert; Tina Highfill; Mohsen Naghavi; Noelle Nightingale; Tara Templin; Martin I Tobias; Theo Vos; Christopher J L Murray Journal: JAMA Date: 2016-12-27 Impact factor: 56.272
Authors: Ben P Hung; Daphne L Hutton; Kristen L Kozielski; Corey J Bishop; Bilal Naved; Jordan J Green; Arnold I Caplan; Jeffrey M Gimble; Amir H Dorafshar; Warren L Grayson Journal: Stem Cells Date: 2015-06-26 Impact factor: 6.277
Authors: Keng Lin Wong; Kevin Boon Leng Lee; Bee Choo Tai; Ping Law; Eng Hin Lee; James H P Hui Journal: Arthroscopy Date: 2013-12 Impact factor: 4.772
Authors: Mohammad A Mandegar; Nathaniel Huebsch; Ekaterina B Frolov; Edward Shin; Annie Truong; Michael P Olvera; Amanda H Chan; Yuichiro Miyaoka; Kristin Holmes; C Ian Spencer; Luke M Judge; David E Gordon; Tilde V Eskildsen; Jacqueline E Villalta; Max A Horlbeck; Luke A Gilbert; Nevan J Krogan; Søren P Sheikh; Jonathan S Weissman; Lei S Qi; Po-Lin So; Bruce R Conklin Journal: Cell Stem Cell Date: 2016-03-10 Impact factor: 24.633